EP3464368
USE OF AN ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN LYMPHOMA TREATMENT
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.6.2017:
28.6.2023:
17730629.7
:
31.5.2037
:
USE OF AN ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN LYMPHOMA TREATMENT
1.6.2017
28.6.2023
:
Bristol-Myers Squibb Company:
Route 206 and Province Line Road, Princeton, NJ 08543, US
:
Seagen Inc.:
21823 30th Drive S.E., Bothell, WA 98021, US
:
FARSACI, Benedetto:
Princeton New Jersey 08543, US
:
JOSEPHSON, Neil:
Bothell Washington 98021, US
:
CAO, Anthony:
Sammamish Washington 98074, US
:
HEISER, Ryan:
Lake Stevens Washington 98258, US
:
201662344866 P:
2.6.2016:
US
:
201662382839 P:
2.9.2016:
US
:
US2017035521:
1.6.2017
:
C07K 16/28, A61K 39/00